Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
319.48
+2.59 (+0.82%)
Streaming Delayed Price
Updated: 10:11 AM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
8
Next >
First Successful Pig Heart Transplant Into Human: Details On The Amazing Technology And A Public Company To Watch
January 11, 2022
Pigs may not be able to fly, but they've provided a vital organ in a life-saving surgery for one U.S. man. What Happened: A Maryland hospital completed the first...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 11, 2022
Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Mark To Market
January 02, 2022
I thought that I would have a look at my own financial performance in 2021. In preview, I did alright, but not as well as the market. Let's take a look at what my portfolio held and how well it did.
Via
Talk Markets
United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst
December 30, 2021
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022
December 03, 2021
From
United Therapeutics Corporation
Via
Business Wire
Liquidia's Inhaled Treprostinil Powder Scores Tentative FDA Approval For PAH
November 08, 2021
The FDA has granted tentative approval to Liquidia Corporation's (NASDAQ: LQDA) Yutrepia (treprostinil) inhalation powder for pulmonary arterial...
Via
Benzinga
Exposures
Product Safety
United Therapeutics Corporation (UTHR) Q3 2021 Earnings Call Transcript
November 03, 2021
UTHR earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Exposures
Pension
Recap: United Therapeutics Q3 Earnings
November 03, 2021
United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the announcement...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...
Via
Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Why Shares of MannKind Corporation Are Falling This Morning
October 18, 2021
Investors are hyperventilating after a delay for its inhaled medicine.
Via
The Motley Fool
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
October 18, 2021
The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary...
Via
Benzinga
Exposures
Product Safety
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer?
September 27, 2021
A biotech working in lung and blood diseases, as well as cancer, could be acquired.
Via
Investor's Business Daily
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients
September 07, 2021
United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary...
Via
Benzinga
Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments
August 05, 2021
Via
FinancialNewsMedia
Why United Therapeutics Blasted 14% Higher Today
August 04, 2021
Every one of the company's products booked a revenue gain in Q2.
Via
The Motley Fool
United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call Transcript
August 04, 2021
UTHR earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
88 Biggest Movers From Yesterday
August 05, 2021
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...
Via
Benzinga
United Therapeutics: Q2 Earnings Insights
August 04, 2021
Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 11.14% over the past...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings
August 04, 2021
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones surged around 280 points in the previous session. Investors are awaiting...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
June 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
Product Safety
Earnings Scheduled For August 4, 2021
August 04, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:
Via
Benzinga
MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension
June 16, 2021
MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing...
Via
Benzinga
Exposures
Product Safety
Price Over Earnings Overview: United Therapeutics
May 06, 2021
Looking into the current session, United Therapeutics Inc. (NASDAQ:UTHR) is trading at $193.48, after a 2.35% decrease. Over the past month, the stock fell by 3.61...
Via
Benzinga
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
May 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.